Literature DB >> 22706292

Initiation of c-ART in HIV-1 infected patients is associated with a decrease of the metabolic activity of the thymus evaluated using FDG-PET/computed tomography.

Jean-Daniel Lelièvre1, Giovanna Melica, Emmanuel Itti, Christine Lacabaratz, Sandra Rozlan, Aurélie Wiedemann, Rémi Cheynier, Michel Meignan, Rodolphe Thiebaut, Yves Levy.   

Abstract

BACKGROUND: The role of the thymus in the depletion or restoration of T-cell pool in HIV infection is still debatable. Studies are hampered by the lack of valuable tools to investigate thymic activity.
METHODS: We have evaluated thymic activity using (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography and molecular and phenotypic analyses of thymic precursors. Longitudinal analyses were performed in HIV-infected patients either treatment naive with indication to initiate combination antiretroviral therapy (c-ART) (n = 11) or stable under c-ART (n = 9).
RESULTS: Thymic standardized uptake value was significantly lower in c-ART-treated patients as compared with historical age-matched HIV-negative controls. In c-ART-naive patients, baseline thymic standardized uptake value correlated with T-cell repector excision circle levels and naive CD4+ T cells. These patients exhibited a high metabolic lymph node activity positively correlated to the percentage of activated HLA-DR+CD38+ T cells. Basal metabolic thymic activity predicts the gain in CD4+ T cells after c-ART initiation. A decrease of thymic activity, which paralleled circulating plasma IL-7 levels, was noted after c-ART initiation. DISCUSSION: A metabolic thymic activity is detectable in c-ART naive and correlates with indirect phenotypic and molecular markers of thymic output. This activity may participate to the pool of peripheral naive CD4+ T cells and predicts the magnitude of T-cell reconstitution under treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706292     DOI: 10.1097/QAI.0b013e3182615b62

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  3 in total

Review 1.  The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases.

Authors:  Alfred O Ankrah; Andor W J M Glaudemans; Hans C Klein; Rudi A J O Dierckx; Mike Sathekge
Journal:  Nucl Med Mol Imaging       Date:  2016-05-25

Review 2.  Assessing immune aging in HIV-infected patients.

Authors:  Victor Appay; Delphine Sauce
Journal:  Virulence       Date:  2016-06-16       Impact factor: 5.882

3.  P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ART.

Authors:  Inna Menkova-Garnier; Hakim Hocini; Emile Foucat; Pascaline Tisserand; Laure Bourdery; Constance Delaugerre; Clarisse Benne; Yves Lévy; Jean-Daniel Lelièvre
Journal:  PLoS Pathog       Date:  2016-04-15       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.